Ogoni indigenes interested in business funding can now register for the 2026 Ogoni Entrepreneurship and Career Development Summit (OES), which will feature a ₦300 million business grant initiative.
The summit is scheduled to hold from December 28 to 30, 2026, at the Ken Saro-Wiwa Memorial Park, Bane, Ogoniland, Rivers State.
The organisers said the event, themed “From Ideas to Enterprises: Building Careers, Financing Businesses and Transforming Ogoni,” would bring together entrepreneurs, professionals and students to promote enterprise growth and career development.
The programme is expected to feature business mentorship, financial literacy sessions, business clinics, pitch competitions, exhibitions, trade fairs, networking and connections with potential investors and partners.
Who can register
Participation is strictly open to indigenes of Ogoniland. The four eligible local government areas are Eleme, Gokana, Khana and Tai.
Business owners, aspiring entrepreneurs, professionals, graduates, job seekers, students, farmers, traders, artisans and skilled workers can register. Applicants must provide their local government area and community of origin for identification and screening.
However, people who received grants under the 2025 OES Summit are not eligible to register for, attend or apply for the 2026 edition. Previous beneficiaries with outstanding business performance may instead be considered for a separate Business Growth and Expansion Support Programme.
The organisers clarified that summit registration does not automatically qualify participants for the ₦300 million grant or guarantee approval to attend. Separate eligibility requirements and application procedures may apply to the grant.
How to apply
Interested Ogoni indigenes should visit https://ogonisummit.org/application/ and complete the official online participant registration form. Applicants must provide personal details, confirm their Ogoni identity, select a participation category and submit relevant business or career information. Registration is subject to screening and approval.





